子痫前期妇女的不良心血管危险因素特征在孕前数年逐渐形成
该回顾性队列研究基于加拿大安大略省行政数据库,纳入2011年1月至2018年12月间单胎初产妇,分析孕前糖化血红蛋白、血糖、血脂和转氨酶等指标的年变化,发现日后发生子痫前期的妇女在孕前数年即已呈现不良心血管危险因素特征并随时间恶化。
要点
- 发生子痫前期的妇女孕前糖化血红蛋白、空腹血糖、随机血糖、低密度脂蛋白胆固醇、甘油三酯和丙氨酸氨基转移酶较高,高密度脂蛋白胆固醇较低(均P < 0.0001)。
- 孕前数年,子痫前期组甘油三酯年增幅为对照组的13.8倍(P = 0.0004),随机血糖年增幅为1.55倍(P = 0.001)。
- 子痫前期组高密度脂蛋白胆固醇年降幅为对照组的9.7倍(P = 0.002),且空腹血糖逐年升高而对照组下降(P = 0.01)。
核心结论
- 在日后发生子痫前期的妇女中,不良心血管危险因素特征在孕前数年随时间逐渐形成。
研究设计与样本
- 回顾性队列研究,使用基于人群的行政数据库,地点为加拿大安大略省。
- 纳入2011年1月至2018年12月间所有单胎妊娠的初产妇。
- 共156 278名妇女,其中3827名发生子痫前期;总体孕前检测次数平均4.0 ± 3.3次。
- 识别2008年1月至妊娠开始期间糖化血红蛋白、血糖、血脂和转氨酶的检测结果,采用广义估计方程估计孕前各指标的年变化。
主要发现
- 最近两次孕前检测的中位时间分别为孕前0.6年和1.9年。
- 子痫前期组孕前糖化血红蛋白、空腹血糖、随机血糖、低密度脂蛋白胆固醇、甘油三酯和丙氨酸氨基转移酶高于对照组,高密度脂蛋白胆固醇低于对照组(均P < 0.0001)。
- 孕前数年,子痫前期组甘油三酯年增幅为对照组的13.8倍(P = 0.0004),随机血糖年增幅为1.55倍(P = 0.001)。
- 子痫前期组高密度脂蛋白胆固醇年降幅为对照组的9.7倍(P = 0.002)。
- 孕前期间,子痫前期组空腹血糖升高而对照组下降(P = 0.01)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Women with a history of pre-eclampsia have an elevated lifetime risk of cardiovascular disease that may be partly attributed to an adverse cardiovascular risk factor profile, the etiology of which is unclear. Hypothesising that this adverse risk profile may begin to arise over time in the years before pregnancy, we sought to evaluate the pregravid changes over time in cardiovascular risk factors in women who go on to develop pre-eclampsia and those who do not. DESIGN: Retrospective cohort study using population-based administrative databases. SETTING: Ontario, Canada. POPULATION: All nulliparous women who had singleton pregnancies between January 2011 and December 2018. METHODS: All results for the following analytes between January 2008 and the start of pregnancy were identified: A1c, glucose, lipids, and transaminases. Mean values were compared between those with and without preeclampsia. The annual change for each analyte in the years before pregnancy was estimated using generalized estimating equations. MAIN OUTCOME MEASURE: Preeclampsia. RESULTS: The 156 278 women (of whom 3827 developed preeclampsia) had mean 4.0 ± 3.3 pregravid tests overall. The two most recent pregravid tests were performed at median 0.6 and 1.9 years before pregnancy, respectively. Women who developed pre-eclampsia had higher pregravid A1c, fasting glucose, random glucose, LDL-cholesterol, triglycerides, and ALT, and lower HDL-cholesterol, than their peers (all P < 0.0001). In the years before pregnancy, women who went on to develop pre-eclampsia had higher annual increases than their peers in triglycerides (13.8-fold higher; P = 0.0004) and random glucose (1.55-fold higher; P = 0.001), coupled with a greater annual decrease in HDL-cholesterol (9.7-fold higher; P = 0.002). During this time, fasting glucose increased in women who developed pre-eclampsia but decreased in their peers (P = 0.01). CONCLUSION: In women who develop pre-eclampsia, an adverse cardiovascular risk factor profile evolves over time in the years before pregnancy. TWEETABLE ABSTRACT: In women who develop pre-eclampsia, an adverse CV risk factor profile evolves in the years before pregnancy.
引用
- Retnakaran R, Shah BR. The adverse cardiovascular risk factor profile of women with pre-eclampsia develops over time in the years before pregnancy. BJOG. 2022. PMID: 34954865. doi:10.1111/1471-0528.17084
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。